Provided is an emulsion composition that is capable of enhancing systemic absorption for various carotenoids, well compatible with soft capsules, and capable of being formulated into a soft capsule formulation, and that homogeneously disperses raw materials including carotenoids and emulsifiers in the soft capsule formulation. An emulsion composition containing a carotenoid, and two or more specific emulsifiers selected from the group consisting of tetraglycerin monooleate, decaglycerin monolaurate, sucrose stearate, and sucrose laurate.
A61K 31/122 - Cétones ayant l'atome d'oxygène lié directement à un cycle, p. ex. quinones, vitamine K1, anthraline
A61K 47/14 - Esters d’acides carboxyliques, p. ex. acides gras monoglycérides, triglycérides à chaine moyenne, parabènes ou esters d’acide gras de PEG
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
A61Q 19/02 - Préparations pour les soins de la peau pour décolorer ou blanchir la peau chimiquement
A61Q 19/08 - Préparations contre le vieillissement
2.
EXERCISE-INDUCED HEMOLYSIS SUPPRESSANT AND COMPOSITION FOR SUPPRESSING/IMPROVING EXERCISE-INDUCED HEMOLYTIC ANEMIA
[Problem] To provide a composition or the like that suppresses the physical destruction of red blood cells (hemolysis) due to exercises and behaviors associated with impact such as striking, for example, as when continually hitting the soles of the feet on the ground by continued running, by using astaxanthin which has a long history of use as a food, and to provide a composition or the like for making the number of red blood cells destroyed (hemolysis number) to lower than the number of red blood cells newly created by hematopoiesis (hematopoiesis number), to suppress and/or improve exercise-induced hemolytic anemia caused by the physical destruction of red blood cells (hemolysis).
[Problem] To provide a composition or the like that suppresses the physical destruction of red blood cells (hemolysis) due to exercises and behaviors associated with impact such as striking, for example, as when continually hitting the soles of the feet on the ground by continued running, by using astaxanthin which has a long history of use as a food, and to provide a composition or the like for making the number of red blood cells destroyed (hemolysis number) to lower than the number of red blood cells newly created by hematopoiesis (hematopoiesis number), to suppress and/or improve exercise-induced hemolytic anemia caused by the physical destruction of red blood cells (hemolysis).
[Solution] Astaxanthin is used as an active ingredient.
[Problem] To provide a composition or the like that suppresses the physical destruction of red blood cells (hemolysis) due to exercise and behaviors associated with impact such as striking, for example, as when continually hitting the soles of the feet on the ground by continued running, by using astaxanthin which has a long history of use as a food, and to provide a composition or the like for making the number of red blood cells destroyed (hemolysis number) lower than the number of red blood cells newly created by hematopoiesis (hematopoiesis number) to suppress and/or improve exercise-induced hemolytic anemia caused by the physical destruction of red blood cells (hemolysis). [Solution] Astaxanthin is used as an active ingredient.
Provided is an emulsion composition that is capable of enhancing systemic absorption for various carotenoids, well compatible with soft capsules, and capable of being formulated into a soft capsule formulation, and that homogeneously disperses raw materials including carotenoids and emulsifiers in the soft capsule formulation. An emulsion composition containing a carotenoid, and two or more specific emulsifiers selected from the group consisting of tetraglycerin monooleate, decaglycerin monolaurate, sucrose stearate, and sucrose laurate.
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
A23L 29/10 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des émulsifiants
A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
The present invention relates to a carotenoid-containing composition for use in exercise therapy for improving cognitive function, particularly exercise therapy for hippocampal neurogenesis.
[Problem] To provide an emulsion composition with which it is possible to improve the absorption of various carotenoids into the body, the emulsion composition having excellent compatibility with soft capsules so as to enable soft-capsule preparations to be formed, and raw materials containing carotenoids and emulsifiers are uniformly dispersed into the soft-capsule preparations. [Solution] An emulsion composition containing: a carotenoid; and two or more prescribed emulsifiers selected from the group consisting of tetraglycerin monooleic acid esters, decaglycerin monolauric acid esters, sucrose stearic acid esters, and sucrose lauric acid esters.
A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
A61K 47/14 - Esters d’acides carboxyliques, p. ex. acides gras monoglycérides, triglycérides à chaine moyenne, parabènes ou esters d’acide gras de PEG
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
The use of at least any one of astaxanthin and an astaxanthin-containing composition for reducing the progression of damage caused to human skin by an external factor, and a method for reducing the progression of damage caused to human skin by an external factor, the method including allowing astaxanthin to be ingested, each according to the present invention, provide a food-and-drink composition, food-and-drink, pharmaceutical composition, and agent to reduce the worsening of the state of damaged human skin.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Pharmaceutical, veterinary and sanitary preparations, namely pharmaceutical, veterinary and sanitary preparations for the treatment of diabetes, for the treatment of dementia, for the treatment of muscle loss, for human and animal skin health, for human and animal eye health, for enhancing muscle performance, for the treatment of cardiovascular diseases, for the treatment of brain health; reagent paper for medical purposes; dietary supplements for general health and well-being for humans, nutritional supplements for general health and well being; dietetic beverages adapted for medical purposes, namely, beverages containing astaxanthin for the treatment and prevention of diabetes, cardiovascular disease, dermatological disease, ocular disease, diseases of the brain, muscular disease, for building body mass, and for promoting weight loss; dietetic food adapted for medical purposes, namely, food containing astaxanthin for the treatment and prevention of diabetes, cardiovascular disease, dermatological disease, ocular disease, diseases of the brain, muscular disease, for building body mass, and for promoting weight loss; dietary supplements for general health and well-being for animals
9.
FOOD OR BEVERAGE COMPOSITION CONTAINING ASTAXANTHIN
[Problem] To provide a food or beverage composition, a food or beverage and the like which include astaxanthin and/or an astaxanthin-containing extract as an active ingredient. [Solution] A food or beverage composition which includes astaxanthin and/or an astaxanthin-containing extract as an active ingredient can, in healthy men and women experiencing,in particular fatigue due to a mental and physical stress, improve the following symptoms: slowed thinking, decreased concentration, decreased motivation, depression, irritation, physical weakness, and decreased activity and/or energy.
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
10.
CAROTENOID-CONTAINING COGNITIVE FUNCTION IMPROVING COMPOSITION FOR USE IN EXERCISE THERAPY FOR COGNITIVE FUNCTION IMPROVEMENT
The present invention pertains to a carotenoid-containing composition for use in an exercise therapy for cognitive function improvement, particularly, in an exercise therapy for neogenesis of hippocampal neurons.
